Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Vertex Pharmaceuticals Incorporated (VRTX) had Current Ratio of 2.90 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.19B |
|
$1.19B |
|
$466.00M |
|
$2.72B |
|
$1.98B |
|
$1.21B |
|
$125.10M |
|
$1.33B |
|
$1.33B |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
$1.21B |
|
$1.26B |
|
255.70M |
|
258.00M |
|
$4.68 |
|
$4.64 |
|
| Balance Sheet Financials | |
$11.20B |
|
$1.52B |
|
$14.44B |
|
$25.64B |
|
$3.86B |
|
-- |
|
$3.12B |
|
$6.98B |
|
$18.67B |
|
$17.15B |
|
$18.67B |
|
253.99M |
|
| Cash Flow Statement Financials | |
$3.63B |
|
$-945.40M |
|
$-2.26B |
|
$4.57B |
|
$5.09B |
|
$515.60M |
|
$685.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.90 |
-- |
|
-- |
|
-- |
|
-- |
|
85.39% |
|
37.80% |
|
37.80% |
|
-- |
|
41.72% |
|
37.34% |
|
$3.19B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.28 |
|
1.55 |
|
57.92 |
|
6.38% |
|
6.94% |
|
4.64% |
|
6.38% |
|
$73.49 |
|
$12.38 |
|
$14.08 |
|